Your browser doesn't support javascript.
loading
Platelet decrease and efficacy of platelet-rich plasma return following peripheral blood stem cell apheresis.
Shima, Takahiro; Sakoda, Teppei; Henzan, Tomoko; Kunisaki, Yuya; Sugio, Takeshi; Kamezaki, Kenjiro; Iwasaki, Hiromi; Teshima, Takanori; Maeda, Takahiro; Akashi, Koichi; Miyamoto, Toshihiro.
Afiliación
  • Shima T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan.
  • Sakoda T; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan.
  • Henzan T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan.
  • Kunisaki Y; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan.
  • Sugio T; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan.
  • Kamezaki K; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan.
  • Iwasaki H; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan.
  • Teshima T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan.
  • Maeda T; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan.
  • Akashi K; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan.
  • Miyamoto T; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan.
J Clin Apher ; 36(5): 687-696, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34133767
ABSTRACT

BACKGROUND:

Peripheral blood stem cell (PBSC) transplantation is a key treatment option for hematological diseases and is widely performed in clinical practice. Platelet loss is one of the major complications of PBSC apheresis, and platelet-rich plasma (PRP) return is considered in case of platelet decrease following apheresis; however, little is known about the frequency and severity of platelet loss and the efficacy of PRP return postapheresis.

METHODS:

We assessed changes in platelet counts following PBSC-related apheresis in 270 allogeneic (allo)- and 105 autologous (auto)-PBSC settings. We also evaluated the efficacy of PRP transfusion on platelet recovery postapheresis.

RESULTS:

In both allo- and auto-PBSC settings, the preapheresis platelet count (range, 84-385 and 33-558 × 109 /L, respectively) decreased postapheresis (range, 57-292 and 20-429 × 109 /L, respectively), whereas severe platelet decrease (<50 × 109 /L) was only observed in auto-PBSC patients (n = 9). We confirmed that platelet count before apheresis was a risk factor for severe platelet decrease (<50 × 109 /L) following auto-PBSC apheresis (odds ratio 0.749, P < .049). PRP return postapheresis facilitated platelet recovery in more than 80% of cases in both allo and auto settings.

CONCLUSION:

Lower platelet count preapheresis is a useful predictor of severe platelet decrease following auto-PBSC apheresis and PRP return is an effective process to facilitate platelet recovery postapheresis.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Eliminación de Componentes Sanguíneos / Trasplante de Células Madre de Sangre Periférica / Plasma Rico en Plaquetas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Apher Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Eliminación de Componentes Sanguíneos / Trasplante de Células Madre de Sangre Periférica / Plasma Rico en Plaquetas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Apher Año: 2021 Tipo del documento: Article País de afiliación: Japón